The newly approved prefilled syringe for self-injection of Vyvgart Hytrulo will provide more convenience and flexibility for patients, experts say.

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

The FDA has approved a subcutaneous self-injectable for adults with generalized myasthenia gravis who are anti-acetylcholine ...

Already thriving with a successful launch of infused Vyvgart and its subcutaneous follow-on Vyvgart Hytrulo to the tune of $2 ...

Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection by a health care professional.

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

Argenx (ARGX) announced that the U.S. Food and Drug Administration approved a new option for patients to self-inject VYVGART Hytrulo with a ...